Health Trials

About this trial

This project will apply a novel non-nutritive sweetener (NNS) dietary assessment tool with measurement of circulating NNS levels in a pediatric population, allowing correlation of NNS exposure to clinically meaningful cardiometabolic health outcomes.

Eligibility criteria

Qualifiers

Aged 15-24 years

Clinical diagnosis of type 1 diabetes, requiring insulin therapy, of ≥ 1 to < 10 years duration.

Last available HbA1c ≤ 8.5% (obtained by chart review in Children's Wisconsin Diabetes Clinic patients or verbally by individuals not receiving diabetes care at Children's Wisconsin)

Current use of an FDA approved automated insulin delivery (AID) system

Disqualifiers

Any disease other than type 1 diabetes that affects glucose, sex steroid, or fat metabolism such as polycystic ovary syndrome or hypercortisolism

Any medication use that may affect glucose, sex steroid, or fat metabolism such as metformin or glucocorticoids

Half or full sibling already participating in this study

Known cardiovascular disease such as hypertension or atherosclerosis, and/or use of an anti-hypertensive medication

Trial design

Treatments tested in this trial

  • Cherry Sports Drink

Treatment groups

20 Participants
are divided into 1 treatment group

Locations

1
Medical College of Wisconsin53226, MilwaukeeWisconsin, United States

Sponsors and collaborators

Medical College of Wisconsin

Lead sponsor

Source ClinicalTrials.gov